# Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain

> **NCT00082316** · PHASE2 · COMPLETED · sponsor: **NeurogesX**

## Conditions studied

- Herpes Zoster
- Neuralgia
- Pain
- HIV Infections
- Peripheral Nervous System Diseases
- Diabetic Neuropathies
- Diabetes Mellitus
- Polyneuropathies

## Interventions

- **DRUG:** Capsaicin Dermal Patch

## Key facts

- **NCT ID:** NCT00082316
- **Lead sponsor:** NeurogesX
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00082316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00082316, "Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00082316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*